agilon health, inc. AGL
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | 5.22% | 11.79% |
| Total Other Revenue | -- | -- | -- | -1.11% | 0.37% |
| Total Revenue | -- | -- | -- | 5.21% | 11.76% |
| Cost of Revenue | -- | -- | -- | 6.15% | 14.81% |
| Gross Profit | -- | -- | -- | -107.85% | -311.49% |
| SG&A Expenses | -- | -- | -- | -13.19% | -13.00% |
| Depreciation & Amortization | -- | -- | -- | 23.85% | 30.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | -- | 5.34% | 13.46% |
| Operating Income | -- | -- | -- | -7.49% | -49.19% |
| Income Before Tax | -- | -- | -- | -3.27% | -52.54% |
| Income Tax Expenses | -- | -- | -- | 4,417.95% | -19.08% |
| Earnings from Continuing Operations | -- | -- | -- | -3.83% | -51.95% |
| Earnings from Discontinued Operations | -- | -- | -- | 119.83% | 116.40% |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -100.00% | -100.00% |
| Net Income | -- | -- | -- | 19.89% | -5.71% |
| EBIT | -- | -- | -- | -7.49% | -49.19% |
| EBITDA | -- | -- | -- | -6.34% | -50.82% |
| EPS Basic | -- | -- | -- | 20.87% | -4.30% |
| Normalized Basic EPS | -- | -- | -- | -1.05% | -50.33% |
| EPS Diluted | -- | -- | -- | 20.92% | -3.39% |
| Normalized Diluted EPS | -- | -- | -- | -1.05% | -50.33% |
| Average Basic Shares Outstanding | -- | -- | -- | 0.91% | 1.10% |
| Average Diluted Shares Outstanding | -- | -- | -- | 0.91% | 1.10% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |